/IQVIA%20Holdings%20Inc%20logo%20and%20chart-by%20IgorGolovniov%20via%20Shutterstock.jpg)
IQVIA Holdings Inc. (IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services for the life sciences industry and is worth a market cap of $34 billion. Headquartered in Durham, North Carolina, IQVIA operates in over 100 countries, offering solutions that enhance clinical trial efficiency, optimize healthcare decision-making, and drive innovation across the industry.
Shares of IQVIA Holdings have underperformed the broader market over the last year. The stock has declined 17.6% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 22.8%. Over the past three months, IQV has surged 2.7%, compared to SPX’s 4.5% rise.
